Directorio de personas
Anna Fernandez Bernal

Anna Fernandez Bernal

Grado: Doctor/a


afernandezb(ELIMINAR)@irblleida.cat

Publicaciones

  • Jové, M; Mota-Martorell, N; Fernàndez-Bernal, A; Portero-Otin, M; Barja, G; Pamplona, R

    Phenotypic molecular features of long-lived animal species

    FREE RADICAL BIOLOGY AND MEDICINE 208 728-747. .

    [doi:10.1016/j.freeradbiomed.2023.09.023]

  • Bernal AF; Mota N; Pamplona R; Area-Gomez E; Portero-Otin M

    Hakuna MAM-Tata: Investigating the role of mitochondrial-associated membranes in ALS.

    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1869 166716-166716. .

    [doi:10.1016/j.bbadis.2023.166716]

  • Sol J; Obis È; Mota-Martorell N; Pradas I; Galo-Licona JD; Martin-Garí M; Fernández-Bernal A; Ortega-Bravo M; Mayneris-Perxachs J; Borrás C; Viña J; de la Fuente M; Mate I; Biarnes C; Pedraza S; Vilanova JC; Brugada R; Ramos R; Serena J; Ramió-Torrentà L; Pineda V; Daunis-I-Estadella P; Thió-Henestrosa S; Barretina J; Garre-Olmo J; Portero-Otin M; Fernández-Real JM; Puig J; Jové M; Pamplona R

    Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome.

    AGING CELL 22 -. .

    [doi:10.1111/acel.13821]

  • Torres, P; Anerillas, C; Ramirez-Nunez, O; Fernàndez A; Encinas, M; Povedano, M; Andres-Benito, P; Ferrer, I; Ayala, V; Pamplona, R; Portero-Otin, M

    The motor neuron disease mouse model hSOD1-G93A shows a non-canonical profile of senescence biomarkers.

    DISEASE MODELS & MECHANISMS 15 -. .

    [doi:10.1242/dmm.049059]

  • Mota-Martorell N; Andrés-Benito P; Martín-Gari M; Galo-Licona JD; Sol J; Fernández-Bernal A; Portero-Otín M; Ferrer I; Jove M; Pamplona R

    Selective brain regional changes in lipid profile with human aging

    Geroscience 44 763-783. .

    [doi:10.1007/s11357-022-00527-1]

  • Torres, P; Andres-Benito, P; Fernàndez-Bernal A; Ricart, M; Ayala, V; Pamplona, R; Ferrer, I; Portero-Otin, M

    Selected cryptic exons accumulate in hippocampal cell nuclei in Alzheimer's disease with and without associated TDP-43 proteinopathy.

    BRAIN 143 20-. .

    [doi:10.1093/brain/awaa013]

Proyectos

  • Desregulacion de TDP-43,eje clave en la ELA: Caracterización de firmas lipidómicas, transcriptómicas y autofágicas en muestras específicas de pacientes para biomarcadores y reposicionamiento
  • Metabolismo lipidico intracelular, procesamiento de ARNm y estrés celular en la encrucijada de la fisiopatología de la esclerosis lateral amiotrófica
  • From GFAP mutations in astrocytes to neurodegeneration: exploring a lipid-protein oxidation pathway (ASTROMAD)
  • The role of defects in mitochondria-associated ER membranes (MAM) to Amyotrophic Lateral Sclerosis